Cargando…
Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus
WHO has declared the outbreak of monkeypox as a public health emergency of international concern. In less than three months, monkeypox was detected in more than 30 000 people and spread to more than 80 countries around the world. It is believed that the immunity formed to smallpox vaccine can protec...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709467/ https://www.ncbi.nlm.nih.gov/pubmed/36466896 http://dx.doi.org/10.3389/fimmu.2022.1023164 |
_version_ | 1784841162659463168 |
---|---|
author | Gushchin, Vladimir A. Ogarkova, Darya A. Dolzhikova, Inna V. Zubkova, Olga V. Grigoriev, Igor V. Pochtovyi, Andrei A. Iliukhina, Anna A. Ozharovskaia, Tatiana A. Kuznetsova, Nadezhda A. Kustova, Daria D. Shelkov, Artem Y. Zrelkin, Denis I. Odintsova, Alina S. Grousova, Daria M. Kan, Vladislav Y. Davtyan, Sona A. Siniavin, Andrei E. Belyaeva, Elizaveta D. Botikov, Andrei G. Bessonova, Arina A. Vasilchenko, Lyudmila A. Vasina, Daria V. Kleymenov, Denis A. Slutskiy, Egor A. Tkachuk, Artem P. Burgasova, Olga A. Loginova, Svetlana Y. Rozhdestvensky, Evgeny V. Shcheblyakov, Dmitry V. Tsibin, Alexander N. Komarov, Andrey G. Zlobin, Vladimir I. Borisevich, Sergei V. Naroditsky, Boris S. Logunov, Denis Y. Gintsburg, Alexander L. |
author_facet | Gushchin, Vladimir A. Ogarkova, Darya A. Dolzhikova, Inna V. Zubkova, Olga V. Grigoriev, Igor V. Pochtovyi, Andrei A. Iliukhina, Anna A. Ozharovskaia, Tatiana A. Kuznetsova, Nadezhda A. Kustova, Daria D. Shelkov, Artem Y. Zrelkin, Denis I. Odintsova, Alina S. Grousova, Daria M. Kan, Vladislav Y. Davtyan, Sona A. Siniavin, Andrei E. Belyaeva, Elizaveta D. Botikov, Andrei G. Bessonova, Arina A. Vasilchenko, Lyudmila A. Vasina, Daria V. Kleymenov, Denis A. Slutskiy, Egor A. Tkachuk, Artem P. Burgasova, Olga A. Loginova, Svetlana Y. Rozhdestvensky, Evgeny V. Shcheblyakov, Dmitry V. Tsibin, Alexander N. Komarov, Andrey G. Zlobin, Vladimir I. Borisevich, Sergei V. Naroditsky, Boris S. Logunov, Denis Y. Gintsburg, Alexander L. |
author_sort | Gushchin, Vladimir A. |
collection | PubMed |
description | WHO has declared the outbreak of monkeypox as a public health emergency of international concern. In less than three months, monkeypox was detected in more than 30 000 people and spread to more than 80 countries around the world. It is believed that the immunity formed to smallpox vaccine can protect from monkeypox infection with high efficiency. The widespread use of Vaccinia virus has not been carried out since the 1980s, which raises the question of the level of residual immunity among the population and the identification of groups requiring priority vaccination. We conducted a cross-sectional serological study of remaining immunity among Moscow residents. To do this, a collection of blood serum samples of age group over 30 years old was formed, an in-house ELISA test system was developed, and a virus neutralization protocol was set up. Serum samples were examined for the presence of IgG antibodies against Vaccinia virus (n=2908), as well as for the ability to neutralize plaque formation with a Vaccinia virus MNIIVP-10 strain (n=299). The results indicate the presence of neutralizing antibody titer of 1/20 or more in 33.3 to 53.2% of people older than 45 years. Among people 30-45 years old who probably have not been vaccinated, the proportion with virus neutralizing antibodies ranged from 3.2 to 6.7%. Despite the higher level of antibodies in age group older than 66 years, the proportion of positive samples in this group was slightly lower than in people aged 46-65 years. The results indicate the priority of vaccination in groups younger than 45, and possibly older than 66 years to ensure the protection of the population in case of spread of monkeypox among Moscow residents. The herd immunity level needed to stop the circulation of the virus should be at least 50.25 – 65.28%. |
format | Online Article Text |
id | pubmed-9709467 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97094672022-12-01 Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus Gushchin, Vladimir A. Ogarkova, Darya A. Dolzhikova, Inna V. Zubkova, Olga V. Grigoriev, Igor V. Pochtovyi, Andrei A. Iliukhina, Anna A. Ozharovskaia, Tatiana A. Kuznetsova, Nadezhda A. Kustova, Daria D. Shelkov, Artem Y. Zrelkin, Denis I. Odintsova, Alina S. Grousova, Daria M. Kan, Vladislav Y. Davtyan, Sona A. Siniavin, Andrei E. Belyaeva, Elizaveta D. Botikov, Andrei G. Bessonova, Arina A. Vasilchenko, Lyudmila A. Vasina, Daria V. Kleymenov, Denis A. Slutskiy, Egor A. Tkachuk, Artem P. Burgasova, Olga A. Loginova, Svetlana Y. Rozhdestvensky, Evgeny V. Shcheblyakov, Dmitry V. Tsibin, Alexander N. Komarov, Andrey G. Zlobin, Vladimir I. Borisevich, Sergei V. Naroditsky, Boris S. Logunov, Denis Y. Gintsburg, Alexander L. Front Immunol Immunology WHO has declared the outbreak of monkeypox as a public health emergency of international concern. In less than three months, monkeypox was detected in more than 30 000 people and spread to more than 80 countries around the world. It is believed that the immunity formed to smallpox vaccine can protect from monkeypox infection with high efficiency. The widespread use of Vaccinia virus has not been carried out since the 1980s, which raises the question of the level of residual immunity among the population and the identification of groups requiring priority vaccination. We conducted a cross-sectional serological study of remaining immunity among Moscow residents. To do this, a collection of blood serum samples of age group over 30 years old was formed, an in-house ELISA test system was developed, and a virus neutralization protocol was set up. Serum samples were examined for the presence of IgG antibodies against Vaccinia virus (n=2908), as well as for the ability to neutralize plaque formation with a Vaccinia virus MNIIVP-10 strain (n=299). The results indicate the presence of neutralizing antibody titer of 1/20 or more in 33.3 to 53.2% of people older than 45 years. Among people 30-45 years old who probably have not been vaccinated, the proportion with virus neutralizing antibodies ranged from 3.2 to 6.7%. Despite the higher level of antibodies in age group older than 66 years, the proportion of positive samples in this group was slightly lower than in people aged 46-65 years. The results indicate the priority of vaccination in groups younger than 45, and possibly older than 66 years to ensure the protection of the population in case of spread of monkeypox among Moscow residents. The herd immunity level needed to stop the circulation of the virus should be at least 50.25 – 65.28%. Frontiers Media S.A. 2022-11-16 /pmc/articles/PMC9709467/ /pubmed/36466896 http://dx.doi.org/10.3389/fimmu.2022.1023164 Text en Copyright © 2022 Gushchin, Ogarkova, Dolzhikova, Zubkova, Grigoriev, Pochtovyi, Iliukhina, Ozharovskaia, Kuznetsova, Kustova, Shelkov, Zrelkin, Odintsova, Grousova, Kan, Davtyan, Siniavin, Belyaeva, Botikov, Bessonova, Vasilchenko, Vasina, Kleymenov, Slutskiy, Tkachuk, Burgasova, Loginova, Rozhdestvensky, Shcheblyakov, Tsibin, Komarov, Zlobin, Borisevich, Naroditsky, Logunov and Gintsburg https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Gushchin, Vladimir A. Ogarkova, Darya A. Dolzhikova, Inna V. Zubkova, Olga V. Grigoriev, Igor V. Pochtovyi, Andrei A. Iliukhina, Anna A. Ozharovskaia, Tatiana A. Kuznetsova, Nadezhda A. Kustova, Daria D. Shelkov, Artem Y. Zrelkin, Denis I. Odintsova, Alina S. Grousova, Daria M. Kan, Vladislav Y. Davtyan, Sona A. Siniavin, Andrei E. Belyaeva, Elizaveta D. Botikov, Andrei G. Bessonova, Arina A. Vasilchenko, Lyudmila A. Vasina, Daria V. Kleymenov, Denis A. Slutskiy, Egor A. Tkachuk, Artem P. Burgasova, Olga A. Loginova, Svetlana Y. Rozhdestvensky, Evgeny V. Shcheblyakov, Dmitry V. Tsibin, Alexander N. Komarov, Andrey G. Zlobin, Vladimir I. Borisevich, Sergei V. Naroditsky, Boris S. Logunov, Denis Y. Gintsburg, Alexander L. Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus |
title | Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus |
title_full | Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus |
title_fullStr | Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus |
title_full_unstemmed | Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus |
title_short | Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus |
title_sort | estimation of anti-orthopoxvirus immunity in moscow residents and potential risks of spreading monkeypox virus |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709467/ https://www.ncbi.nlm.nih.gov/pubmed/36466896 http://dx.doi.org/10.3389/fimmu.2022.1023164 |
work_keys_str_mv | AT gushchinvladimira estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT ogarkovadaryaa estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT dolzhikovainnav estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT zubkovaolgav estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT grigorievigorv estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT pochtovyiandreia estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT iliukhinaannaa estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT ozharovskaiatatianaa estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT kuznetsovanadezhdaa estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT kustovadariad estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT shelkovartemy estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT zrelkindenisi estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT odintsovaalinas estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT grousovadariam estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT kanvladislavy estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT davtyansonaa estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT siniavinandreie estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT belyaevaelizavetad estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT botikovandreig estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT bessonovaarinaa estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT vasilchenkolyudmilaa estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT vasinadariav estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT kleymenovdenisa estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT slutskiyegora estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT tkachukartemp estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT burgasovaolgaa estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT loginovasvetlanay estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT rozhdestvenskyevgenyv estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT shcheblyakovdmitryv estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT tsibinalexandern estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT komarovandreyg estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT zlobinvladimiri estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT borisevichsergeiv estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT naroditskyboriss estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT logunovdenisy estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus AT gintsburgalexanderl estimationofantiorthopoxvirusimmunityinmoscowresidentsandpotentialrisksofspreadingmonkeypoxvirus |